×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
2922 views

Modérateur : Alexandre de Nonneville

Au programme de cette soirée

18:00 Introduction
 
18:05 Testing HER2, le point de vue de l'anapath
Camille Franchet
 
18:25 HER2-faible, une nouvelle entité dans le cancer du sein ?
Alexandre de Nonneville
 
18:45 Premières lignes des cancers du sein métastatiques HER2-faible
Ophélie Cassuto
 
19:05 Place et séquence des ADC dans les cancers du sein métastatiques HER2-faible
François Bertucci
 
19:25 Débat/discussion - Réponses aux questions
 

 


Webinar #1   Webinar #3

 

Shooting date : 2024-02-01
Last update : 2024-04-03

Suggestions

Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Honolulu : Thursday, March 10th 2022 from 08am to 10am (GMT+1)
San Francisco : Thursday, March 10th 2022 from 10am to 12pm (GMT+1)
New York : Thursday, March 10th 2022 from 01pm to 03pm (GMT+1)
Buenos Aires : Thursday, March 10th 2022 from 03pm to 05pm (GMT+1)
London / Dublin : Thursday, March 10th 2022 from 06pm to 08pm (GMT+1)
Paris / Berlin : Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Istanbul : Thursday, March 10th 2022 from 08pm to 10pm (GMT+1)
Moscou / Dubaï : Thursday, March 10th 2022 from 10pm to 12am (GMT+1)
Bangkok : Friday, March 11th 2022 from 01am to 03am (GMT+1)
Shanghai : Friday, March 11th 2022 from 02am to 04am (GMT+1)
Tokyo : Friday, March 11th 2022 from 03am to 05am (GMT+1)
Sydney : Friday, March 11th 2022 from 04am to 06am (GMT+1)
Wellington : Friday, March 11th 2022 from 06am to 08am (GMT+1)

Changement de paradigme dans les cancers du sein triple négatif métastatique - de la théorie à l...

Share
Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 13th 2022 from 07am to 08am (GMT+2)
San Francisco : Thursday, October 13th 2022 from 10am to 11am (GMT+2)
New York : Thursday, October 13th 2022 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, October 13th 2022 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, October 13th 2022 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, October 13th 2022 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, October 13th 2022 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 13th 2022 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, October 13th 2022 from 09pm to 10pm (GMT+2)
Bangkok : Friday, October 14th 2022 from 12am to 01am (GMT+2)
Shanghai : Friday, October 14th 2022 from 01am to 02am (GMT+2)
Tokyo : Friday, October 14th 2022 from 02am to 03am (GMT+2)
Sydney : Friday, October 14th 2022 from 04am to 05am (GMT+2)
Wellington : Friday, October 14th 2022 from 06am to 07am (GMT+2)

Les inhibiteurs de tyrosine kinase (TKI) et les anticorps conjugués (ADC) dans le cancer du sein mÃ...

Les nouveaux traitements, entre choix et complémentarité

Share
Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, May 14th 2024 from 07am to 08:30am (GMT+2)
San Francisco : Tuesday, May 14th 2024 from 10am to 11:30am (GMT+2)
New York : Tuesday, May 14th 2024 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Tuesday, May 14th 2024 from 02pm to 03:30pm (GMT+2)
Reykjavik : Tuesday, May 14th 2024 from 05pm to 06:30pm (GMT+2)
London / Dublin : Tuesday, May 14th 2024 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Tuesday, May 14th 2024 from 07pm to 08:30pm (GMT+2)
Istanbul : Tuesday, May 14th 2024 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Tuesday, May 14th 2024 from 09pm to 10:30pm (GMT+2)
Bangkok : Wednesday, May 15th 2024 from 12am to 01:30am (GMT+2)
Shanghai : Wednesday, May 15th 2024 from 01am to 02:30am (GMT+2)
Tokyo : Wednesday, May 15th 2024 from 02am to 03:30am (GMT+2)
Sydney : Wednesday, May 15th 2024 from 04am to 05:30am (GMT+2)
Wellington : Wednesday, May 15th 2024 from 06am to 07:30am (GMT+2)

Développement thérapeutique dans les cancers du sein triples négatifs métastatiques

Les webinars du réseau FEM-NET

Share
Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, March 13th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Wednesday, March 13th 2024 from 09am to 10:30am (GMT+1)
New York : Wednesday, March 13th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Wednesday, March 13th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Wednesday, March 13th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Wednesday, March 13th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Wednesday, March 13th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Thursday, March 14th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Thursday, March 14th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Thursday, March 14th 2024 from 02am to 03:30am (GMT+1)
Sydney : Thursday, March 14th 2024 from 03am to 04:30am (GMT+1)
Wellington : Thursday, March 14th 2024 from 05am to 06:30am (GMT+1)

Prise en charge du cancer HER2+ métastatique

Cycle d'enseignement - Le cancer du sein

Share
Scroll Up